Table 4. Primary Outcomes—Absolute COP MTV (mm/s) and Relative Stability Indices.
Group Mean(SD) | ||||||
---|---|---|---|---|---|---|
Group | Outcome | Baseline | Post | 95% CI of the Mean Difference | P-value | Effect Size (η2) |
AYT | FirmEO | 11.91 (3.14) | 12.02 (2.21) | -0.10 (-2.39 2.18) | 0.92 | 0.00 |
FirmEC | 12.65 (2.62) | 13.04 (2.50) | -0.39 (-2.35 1.58) | 0.66 | 0.03 | |
FoamEO | 22.62 (6.12) | 29.03 (7.49) | -6.41 (-10.45–2.37) | 0.01* | 0.63 | |
FoamEC | 22.90 (3.19) | 33.09 (10.03) | -10.19 (-16.22–4.16) | 0.01* | 0.66 | |
Waitlist | FirmEO | 14.07 (5.01) | 14.28 (4.38) | -0.21 (-2.26 1.84) | 0.82 | 0.01 |
FirmEC | 13.49 (4.93) | 14.49 (4.14) | -1.00 (-2.86 0.86) | 0.24 | 0.19 | |
FoamEO | 23.82 (8.25) | 25.83 (6.70) | -2.00 (-6.82 2.80) | 0.36 | 0.12 | |
FoamEC | 27.80 (7.30) | 31.08 (8.29) | -3.29 (-8.98 2.40) | 0.21 | 0.21 | |
AYT | SIFirm | 0.02 (0.08) | 0.03 (0.04) | -0.01 (-0.07 0.06) | 0.82 | 0.01 |
SIFoam | 0.01 (0.08) | 0.03 (0.04) | -0.02 (-0.07 0.03) | 0.34 | 0.11 | |
SIEO | 0.19 (0.06) | 0.24 (0.07) | -0.05 (-0.10–0.01) | 0.04* | 0.42 | |
SIEC | 0.18 (0.07) | 0.25 (0.05) | -0.07 (-0.11–0.03) | 0.01* | 0.66 | |
SIV | 0.20 (0.08) | 0.26 (0.06) | -0.07 (-0.13–0.01) | 0.04* | 0.43 | |
Waitlist | SIFirm | -0.02 (0.03) | 0.01 (0.05) | -0.02 (-0.06 0.02) | 0.24 | 0.19 |
SIFoam | 0.05 (0.08) | 0.05 (0.05) | 0.00 (-0.08 0.08) | 1.00 | 0.00 | |
SIEO | 0.16 (0.03) | 0.17 (0.08) | -0.16 (-0.08 0.05) | 0.58 | 0.05 | |
SIEC | 0.21 (0.06) | 0.21 (0.06) | 0.01 (-0.07 0.07) | 0.97 | 0.00 | |
SIV | 0.20 (0.06) | 0.22 (0.06) | -0.02 (-0.08 0.04) | 0.48 | 0.07 |
Primary outcomes are analyzed by paired samples t-tests. 95% CI are confidence intervals for the mean difference pre-post t-tests. Effect sizes for primary outcomes were calculated as the partial eta squared, η2 = t2/(t2 + (N-1)). We use the Ferguson (2009) effect size criteria for η2: small = 0.2, moderate = 0.5, large = 0.8. SI = Stability Index, EO = Eyes Open, EC = Eyes Closed, V = Vestibular,
* = Statistically significant.